AltaValve™ TMVR System

About 4C Medical

4C Medical is an emerging player in the high-growth transcatheter mitral valve intervention market, developing its innovative AltaValve™ system. The technology is distinguished by its supra-annular, atrial-only fixation, which aims to address key limitations of current TMVR technologies, such as left ventricular outflow tract (LVOT) obstruction and damage to critical heart structures. The company is currently in the investigational stage, having conducted early feasibility studies, and is led by a team with deep experience in cardiovascular device development and commercialization. 4C Medical's strategy targets a significant unmet need in treating both primary and secondary MR patients who are at high surgical risk.

Therapeutic Areas